Karolinska Development AB (OSTO:KDEV) Dividends per Share : kr0.00 (TTM As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Karolinska Development AB Dividends per Share?

Karolinska Development AB's dividends per share for the three months ended in Mar. 2024 was kr0.00. Its dividends per share for the trailing twelve months (TTM) ended in Mar. 2024 was kr0.00. Its Dividend Payout Ratio for the three months ended in Mar. 2024 was 0.00. As of today, Karolinska Development AB's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.

Karolinska Development AB Dividends per Share Historical Data

The historical data trend for Karolinska Development AB's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Karolinska Development AB Dividends per Share Chart

Karolinska Development AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dividends per Share

Get a 7-Day Free Trial

Karolinska Development AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Dividends per Share	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Karolinska Development AB's Dividends per Share

For the Biotechnology subindustry, Karolinska Development AB's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Karolinska Development AB's Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Karolinska Development AB's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Karolinska Development AB's Dividend Yield % falls into.

Karolinska Development AB Dividends per Share Calculation

Dividends paid to per common share.

Karolinska Development AB (OSTO:KDEV) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Karolinska Development AB's Dividend Payout Ratio for the quarter that ended in Mar. 2024 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Mar. 2024 )	/	Earnings per Share (Diluted) (Q: Mar. 2024 )
	=	0	/	0.001
	=	0.00

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

Karolinska Development AB Dividends per Share Related Terms

Thank you for viewing the detailed overview of Karolinska Development AB's Dividends per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Karolinska Development AB (OSTO:KDEV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Karolinska Development AB (OSTO:KDEV) » Definitions » Dividends per Share

Comparable Companies

Traded in Other Exchanges

2I9:Germany

Address

TomtebodavAgen 23 A, Solna, SWE, SE-171 65

Website

https://www.karolinskadevelopment.com

Karolinska Development AB is a life science investment company. It is focused on identifying breakthrough medical innovations in the Nordic region. It selects commercially attractive medical innovations, develops innovations to the stage where the return on investment can be achieved and commercializes the innovations through the sale of companies or out-licensing of products. The company focused on profiles namely Aprea Therapeutics; Modus Therapeutics; BioArctic; Umecrine Cognition; and OssDsign.

Karolinska Development AB (OSTO:KDEV) Headlines

No Headlines